Follow-up schedule | Screening/enrolment/baseline | Follow-up 1 | Subsequent Follow-ups |
---|---|---|---|
Timeline | Week −2 or 0a, b | Month 1 | Month 3 and every 3 months thereafterc |
Informed consent | X | ||
Review eligibility | X | X | X |
Medical historyd | X | ||
Renal function (creatinine clearance) | X | Xe | |
Serious adverse events, pregnancy (if applicable) | X | X | |
Hepatitis C testing | X | Xf | |
STI testing g | X | X | |
HIV testingg | X | X | X |
Dispense study medication | X | X | X |
Survey of adherence and behaviour | X | Xh |